This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

American Dairy Falls 40% as Growth Wanes

American Dairy (ADY) saw its New York-listed shares crash by more than 40% Monday after it put the brakes on investor expectations for further explosive growth this year.

An oddly named company, American Dairy, based in Beijing, derives nearly all of its revenue from the manufacture and sale of baby formula in China. Publicly traded in the U.S. since 2003, its stock has increased sharply in value since last year, when the company emerged unscathed from the Chinese baby-formula contamination outbreak that killed six infants and bankrupted a rival.

As a result, American Dairy took market share and posted revenue growth on the order of 190% year-over-year. Its stock ballooned from a 52-week low of $6.40 last September to a peak of $44 as recently as last month as retail investors, hoping for continued skyrocketing sales, piled into the stock.

But on Monday, American Dairy issued its reduced guidance, saying second-quarter revenue would increase by just 10% from the year-earlier period.

Slated to release official results later in the month, the company said quarterly revenue would likely come in at $41 million, up from $37 million a year ago, but well below the nearly $80 million it posted in the fourth quarter of 2008.

The reason for that stalled growth? In its press release, the company cited stiffer Chinese regulations in the wake of the contamination scandal, which require new labels with more information disclosed on them.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
FB $80.60 0.39%
GOOG $540.24 1.20%
TSLA $248.29 -0.47%
YHOO $43.14 -0.47%
AAPL $130.33 -0.16%

Markets

DOW 18,045.58 +5.21 0.03%
S&P 500 2,116.68 +4.95 0.23%
NASDAQ 5,096.2550 +13.3260 0.26%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs